The Brompton Fountain Trustee Professor Louise Fleming is leading on the following:

Some children and young people with asthma in the United Kingdom continue to have poor control and frequent asthma attacks, despite effective therapies being available. Asthma symptoms and attacks are usually treated with a reliever medication (blue inhaler) that briefly opens the airways. But the effects wear off and blue inhalers don’t treat the underlying problem of airway inflammation (swelling).

There is a combination inhaler designed to relieve the immediate symptoms whilst also working on the underlying airway inflammation. This inhaler has been shown to work well in adults and teenagers; however, it is not currently available as a reliever to children under 12 years old. Therefore, we aim to assess whether this type of combination inhaler works more effectively than the current treatment in children aged 6-11 years.